Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
出版年份 2013 全文链接
标题
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
作者
关键词
-
出版物
SCIENCE
Volume 341, Issue 6141, Pages 84-87
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2013-07-05
DOI
10.1126/science.1233606
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours
- (2012) E Dean et al. BRITISH JOURNAL OF CANCER
- The Development of MetAP-2 Inhibitors in Cancer Treatment
- (2012) S.-Q. Yin et al. CURRENT MEDICINAL CHEMISTRY
- The Antifolates
- (2012) Michele Visentin et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
- (2012) Elisabet Wahlberg et al. NATURE BIOTECHNOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Profiling Cellular Protein Complexes by Proximity Ligation with Dual Tag Microarray Readout
- (2012) Maria Hammond et al. PLoS One
- Positron emission tomography molecular imaging for drug development
- (2011) Paul M. Matthews et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor
- (2011) X. Liu et al. CLINICAL CANCER RESEARCH
- Mechanisms of drug resistance in kinases
- (2011) Rina Barouch-Bentov et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The CDK inhibitors in cancer research and therapy
- (2011) Jonas Cicenas et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PARP inhibitors stumble in breast cancer
- (2011) Malini Guha NATURE BIOTECHNOLOGY
- Trends in the exploitation of novel drug targets
- (2011) Mathias Rask-Andersen et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of Direct Protein Targets of Small Molecules
- (2010) Brett Lomenick et al. ACS Chemical Biology
- Deconstructing the Drug Development Process: The New Face of Innovation
- (2010) K I Kaitin CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- GSK/Sirtris compounds dogged by assay artifacts
- (2010) Charlie Schmidt NATURE BIOTECHNOLOGY
- PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas
- (2010) John T. Lee et al. Pigment Cell & Melanoma Research
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression
- (2009) D. S. Auld et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Target identification using drug affinity responsive target stability (DARTS)
- (2009) B. Lomenick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thermodynamic Analysis of Protein Stability and Ligand Binding Using a Chemical Modification- and Mass Spectrometry-Based Strategy
- (2008) Graham M. West et al. ANALYTICAL CHEMISTRY
- Pharmacokinetics in Drug Discovery
- (2007) Ana Ruiz-Garcia et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now